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ABSTRACT 
 
Three-dimensional (3D) cancer models are overlooking the scientific landscape with the 
primary goal of bridging the gaps between two-dimensional (2D) cell cultures, animal 
models and clinical research. In this thesis, we describe an innovative tissue 
engineering approach applied to colorectal cancer (CRC) starting from decellularized 
human biopsies in order to generate an organotypic 3D bioactive model. This in vitro 
3D system recapitulates the ultrastructural environment of native tissue as 
demonstrated by histology, immunohistochemistry, immunofluorescence and scanning 
electron microscopy analyses. Mass spectrometry of proteome and secretome 
confirmed a different stromal composition between decellularized healthy mucosa and 
CRC in terms of structural proteins (COL1A1, COL1A2, and COL3A1) and secreted 
proteins such as DEFA3. Importantly, we proved that our 3D acellular matrices retained 
their biological properties: using CAM assay, we observed a decreased angiogenic 
potential in decellularized CRC compared with healthy colon mucosa, caused by direct 
effect of DEFA3. In addition, we demonstrated that following a 5 days of recellularization 
with HT-29 cell line, the 3D tumor matrices induced an over-expression of IL-8, a 
DEFA3-mediated pathway and a mandatory chemokine in cancer growth and 
proliferation, compared with recellularized healthy mucosa and 2D conventional culture 
model. Given the biological activity maintained by the scaffolds after decellularization, 
we believe this approach is a powerful tool for future pre-clinical research and 
screenings. 
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INTRODUCTION 
 
 
Colorectal Cancer: epidemiology, risk factors and classification 
According to the American Cancer Society's 2017 statistics, cancer is the second 
leading cause of death in the world and will become the first cause of death in 
industrialized countries over the next two decades, overcoming cardiovascular diseases 
[1]. Incidence and mortality rates of Colorectal cancer (CRC) vary markedly around the 
world. The highest incidence rates are in Australia/New Zealand, Europe, and Northern 
America. Rates are low in Africa and South-Central Asia. Both incidence and mortality 
are higher in men than in women in most parts of the world [1]. 
Tumors of the gastrointestinal tract represent a serious public health problem due to the 
high incidence and mortality in the world population. In Europe, tumors of the 
gastrointestinal tract are the most common: more than half are represented by CRC, 
affecting about 250000 individuals per year representing 9% of all cancer diagnosed in 
Europe [2]. 
The incidence of CRC correlates with industrialization and urbanization to indicate how 
environmental factors together with diet and lifestyle can be considered the major risk 
factors. Among these of particular importance are: a diet rich in fat and meat, cigarette 
smoking, the use of non-steroidal anti-inflammatory drugs, alcohol, sedentary lifestyle 
and obesity. Conversely, a discrete contribution of folic acid, vitamins, fibers and 
periodic medical visits contributes to decreasing the risk of CRC [3].  
CRC is a heterogeneous disease that originates from a multi-stage biological process 
characterized by progressive deregulation in the oncogene and oncosuppressor genes. 
Such genotype alterations are associated to phenotypic alterations characterized by the 
progressive de-differentiation of colic epithelial, the so-called “adenoma-carcinoma 
sequence” [4] (Figure 1). 
4 
 
  
 
 
 
 
 
 
 
 
Figure 1: Anatomo-pathological evolution of the adenoma-carcinoma sequence. 
 
 
Approximately 25% of CRCs are hereditary [5]. Among these, the most common are: 
Familial Adenomatous Polyposis (FAP), with abnormalities in the APC gene 
(Adenomatous Polyposis Coli), a dominant autosomal pathology characterized by the 
spread of adenomatous polyps in the colon and rectum already after the second decade 
of life and Lynch syndrome or Hereditary Non-polypotic Colon Cancer (HNPCC) caused 
by a mutation in the genes involved in the mismatch repair genes such as MLH1, MSH2 
and MSH6. With lower incidence there are also Peutz-Jegher's syndrome and Juvenile 
polyposis both dominant autosomal pathologies characterized by the manifestation of 
hamartomatous polyps along the gastrointestinal tract. The remaining 75% of CRC is 
of sporadic origin. The acquisition of genetic instability as key event of tumor 
progression is to be attributed to three main genetic factors: 85% of sporadic CRCs 
exhibit chromosomal instability (CIN) in the form of structural or numerical anomalies of 
the chromosomes in the tumor cells. About 10% of sporadic CRCs are characterized 
by microsatellite instability (MSI), associated with the biallelic inactivation of genes 
involved in DNA repair. Finally, 5% of sporadic CRCs show a characteristic epigenomic 
instability understood both as global hypomethylation and as an alteration in methylation 
of the CpG (CIMP) [6]. 
The most common CRC classification, both sporadic and hereditary, is the TNM 
classification system of the American Joint Committee on Cancer (AJCC). The TNM 
system has been in force around the world since the mid-1980s and is based on the 
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evaluation of three parameters: parameter T (Tumor), indicates the degree of invasion 
of the intestinal wall; parameter N (Node), indicates the degree of involvement of 
locoregional lymph nodes; the parameter M (Metastasis), indicates the presence or 
absence of metastasis [7] (Table 1). 
Patients with CRC stage I, II and III have 5-year Disease-Specific Survival rates (DSS 
rates) of 95%, 84.7% and 68.7%, respectively, and 5-year Overall Survival rates (OS 
rates) of 82.7%, 70.3% and 58.3%, respectively. CRCs that have spread to other parts 
of the body are often harder to treat and tend to have a poorer outcome. Metastatic, or 
stage IV colon cancers, have a 5-year OS rate of about 11% [8]. 
 
 
Table 1. TNM classification system of the AJCC, according to the “TNM Classification of Malignant 
Tumours, 7th Edition”. 
 
 
 
AJCC 
stage 
TNM 
classification 
TNM stage criteria for colorectal cancer 
Stage 0 Tis, N0, M0 Tis: Tumor confined to mucosa; cancer-in-situ  
 
Stage I 
 
T1, N0, M0 
T2, N0, M0 
T1: Tumor invades sub mucosa  
T2: Tumor invades muscularis propria 
Stage IIA T3, N0, M0 
 
T3: Tumor invades subserosa or beyond 
(without other organs involved)  
Stage IIB T4a, N0, M0 T4a: Tumor penetrates to the surface of the 
visceral peritoneum 
Stage IIC T4b, N0, M0 T4b: Tumor directly invades or is adherent to 
other organs or structures 
Stage IIIA T1-2, N1, M0 
T1, N2a, M0 
N1: Metastasis to 1 to 3 regional lymph nodes. 
Stage IIIB  T3-4a, N1, M0 
T2-T3, N2a, M0 
T1-T2, N2b, M0 
N1: Metastasis to 1 to 3 regional lymph nodes. 
Stage IIIC T4a, N2, M0 
T3-T4a, N2b, M0 
T4b, N1-N2, M0 
N2: Metastasis to 4 or more regional lymph 
nodes 
Stage IV any T, any N, 
M1a/b 
M1: Distant metastases present; 
M1a: Metastasis confined to one organ or site; 
M1b: Metastases in more than one organ/site or 
the peritoneum 
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Tumor microenvironment and extracellular matrix: the context matter 
The extensive studies on cancer, allow us to affirm that tumors arise from a normal cell 
following sequential gene alterations that perturb its finely tuned homeostatic system. 
Twenty years ago, Hanahan and Weinberg proposed the six hallmarks of cancer, the 
fundamental, distinctive and complementary capabilities that enable tumor growth and 
metastatic dissemination: sustaining proliferative signaling, evading growth 
suppressors, resisting cell death, enabling replicative immortality, inducing 
angiogenesis, and activating invasion and metastasis [9]. The scientific efforts of the 
researchers, in the last ten years, have made it possible a conceptual progression by 
adding two emerging hallmarks of cancer: reprogramming of energy metabolism and 
evading immune destruction. In addition, the same authors in their second publication, 
recognized to the tumors another grade of complexity: a repertoire of recruited normal 
cells that contribute to the acquisition of hallmark traits by creating permissive and 
promoting environment for cancer onset and progression [10]. 
However, the tumor cell-centric view of cancer does not take into account the context 
in which malignant cells subsist. As the cancer progresses, the surrounding 
microenvironment co-evolves into an activated state through continuous paracrine 
communication, creating a dynamic signaling circuitry that promotes cancer initiation 
and growth. A cancer is now recognized, as a complex tissue composed of multiple 
distinct cell types and a non-cellular compartment, within which tumor cells establish, 
the so-called: tumor microenvironment (TME) [11]. 
The TME is composed by a various stromal components, including endothelial cells, 
pericytes, cancer-associated fibroblasts, various classes of leukocytes, myeloid cells, 
and extracellular matrix (ECM) [12]. This thesis focuses its attention on the non-cellular 
component of TME, which is also the most abundant and less studied of the tumor 
niche: the ECM [13]. The ECM does not only serve as a scaffold upon which tissues 
are organized but provides critical biochemical and biomechanical properties that affect 
cell growth, survival, migration and differentiation [14]. The composition of ECM is 
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extremely complex and organ-specific. Usually ECM is composed by a complex network 
of macromolecules that assemble into three-dimensional structures and can be 
classified into two major types that vary in composition and structure: the pericellular 
matrices, in close contact with cells, and interstitial matrices, which surround cells. 
Basement membrane, for example, is a type of pericellular matrix, that works as 
interface between parenchyma and connective tissue providing an anchoring sheet-like 
layer for parenchymal cells. Basement membranes are principally composed of 
collagen type IV, laminins, nidogen 1 and 2, perlecan, agrin, collagen type XV, and 
collagen type XVIII [15]. 
Conversely, cells embedded into interstitial matrices, interact through their surface 
receptors, such as integrins, discoidin domain receptors and the hyaluronan receptor 
CD44 with a macromolecular network composed of proteoglycans, 
glycosamminoglicans, collagens, hyaluronic acid, secreted factors and 
metalloproteases. In the homeostatic processes both the cellular and extracellular 
components of the stroma are finely regulated and continuously remodeled by all 
cellular types (i.e. epithelial, fibroblasts, immune cells, endothelial cells). Biological 
messages received from ECM dictate cells functions and behaviors. Various growth 
factors, cytokines, and chemokines are deposited within ECM through binding to 
specific ECM molecules and are able upon well-orchestrated procedures to be released 
and operate at the right time in the right region. In this context, the critical aspect of the 
ECM is that it is dynamically remodeled and specifically tailored to the structure/function 
of each organ. In addition, its composition, biomechanics and anisotropy reflects the 
physiological state of the tissue. In fact, in the particular case of cancer onset it was 
demonstrated an increased deposition and an altered organization of ECM proteins 
similar to a fibrotic state, called desmoplasia [16]. 
The studies on the role of the ECM as an active component in the modulation of tumor 
behavior is only at the dawn, but some works have demonstrated its pro-active role in 
tumor development and progression. For example, patients with pancreatic cancer 
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show a marked stromal desmoplasia that often associates with tumor progression and 
poor disease outcome [17]. Similarly, expression of matrix remodeling genes such as 
metallo proteases (MMPs) and collagen cross-linkers is predictive of a poor prognosis 
for breast cancer patients [18, 19].  Fibrosis can also predispose a tissue to malignancy; 
patients with liver cirrhosis or cystic fibrosis, conditions that are characterized by 
abnormal accumulation of collagen, have an increased risk of developing cancer [20, 
21]. Moreover, increased mammographic density, which associates with increased 
collagen deposition, correlates with an elevated risk of developing breast cancer [22]. 
Indeed, MMPs and high mechanical stress are predictive of tumor formation in breast 
cancer patients [22]. In CRC, in recent years, it has been understood that the 
characterization of TME is an indispensable condition for better clustering patients and 
identifying a tailored therapeutic approach. These findings culminated in the proposal 
of a new CRC classification based on the genetic profile coupled with the peculiar 
characteristics of TME [23]. However, there is still a large gap to be covered since all 
cellular components of TME have been extensively studied but, the ECM has not been 
studied as much in detail, even though is the most abundant part of the tumor stroma 
and is far from being amorphous and without biological activity.   
In conclusion, the ECM regulates many of the same cellular responses that characterize 
the cancer hallmarks. This overlap suggests that the biochemical and biophysical 
properties of the ECM should be better studied using innovative approaches widely 
employed in other fields of science such as regenerative medicine. 
 
Three-dimensional colorectal cancer models 
The best experimental approach to study a highly complex pathological condition such 
as cancer is to comprehensively understand the mechanisms responsible for the onset, 
progression and diffusion. However, in such a complicated tumor microenvironment it 
is difficult to understand, with current technologies, the key role of biological, 
biochemical, biomechanical and biophysical factors that might drive human 
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pathophysiology in an omni-comprehensive model. The natural reaction against this 
challenge is to deconstruct the complex cellular microenvironment into a simpler and 
more predictable system. In this scenario, most of the studies has traditionally relied on 
two-dimensional (2D) cultures and probably much of what we know about cancer 
derives from the use of this experimental model. In this model, the cells grown flat and 
adherent as monocultures on functionalized plastic culture plates. The main advantages 
of this model are: a) cells grow easily and are easy to maintain; b) cells are pure and 
free from contaminating cells; c) the manipulation of cells such as induction/silencing of 
a protein, stimulation with biological factor and/or chemo-radiotherapeutic treatment are 
relatively easy; d) the methods for the cytotoxicity evaluation of a molecule are simple, 
highly standardized and repeatable and e) the methods of protein/RNA/DNA extraction 
are relatively simple [24]. However, adherent cultured cell shows clear limitations that 
have encouraged the development of three-dimensional (3D) models. It is now well 
accepted that monolayer cells do not grow in a physiological environment that leads 
them to assume different shapes and behaviors from what observed in vivo. In details, 
cells are forced to polarize and increase their exchange area to culture media due to 
the attachment to rigid and flat substrates. This led to an over-nutrition, over-
oxygenation and non-reproducibility of the in vivo molecular gradients. In addition, in 2D 
setting the composition, configuration and production of ECM are significantly altered 
or even absent. Finally, even more evident in the anticancer treatments research, is the 
fact that cells can behave differently depending on their environment and on culture 
conditions: medium supplements, cell density, and the composition of the culture 
surface have a critical impact on cell proliferation, differentiation, migration, and death 
by affecting intracellular signal transduction leading to unpredictable reactions to 
exogenous stimuli [25]. Realizing that monolayer adherent culture cannot recapitulate 
in vivo native tumor complexity researchers have developed various 3D models that 
recapitulate certain features of solid tumor tissues, such as tumor morphology, gradient 
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distribution of chemical and biological factors, dynamic and reciprocal 
interactions/constraints between tumor and its stroma.  
The addition of the third dimension to cell culture in cancer research dates back to the 
'70s with the seminal experiment of Sutherland et colleagues that by cultivating Chinese 
hamster V79 lung cells in suspension culture obtained spheroids morphologically 
resembling mammary carcinoma nodules [26]. From then on, a series of studies with 
different methods and different aims followed. In solid tumors, multicellular tumor 
spheroids can mimic inner avascular structure of neoplastic lesions in terms of growth 
kinetics, biochemical stimuli, tissue oxygenation and nutrients supply, fundamental 
condition completely absent in 2D culture systems. In this setting indeed, cells in the 
outer layer, that form a rim of 100-300 μm, are in active proliferation because they have 
adequate access to nutrients and oxygen, simulating in vivo the vascularized site of the 
tumor near the capillaries. While core cells show a quiescent phenotype or even form 
an apoptotic/necrotic core due to the limited diffusion of oxygen and nutrients, 
accumulation of waste and pH decreasing [27]. With these premises, Soranzo and 
Ingrosso et colleagues [28], growing LoVo human colon carcinoma cells using the liquid 
overlay technique successfully cultivated a prototype of multicellular tumor spheroids. 
Initially, they observed that growth kinetics was different if compared with monolayer 
culture. In detail, LoVo spheroids showed a doubling time of 5 days vs 37 h of monolayer 
cells. In addition, they observed that cell ultrastructure and organization 
in spheroids closely resembled those of the same cells when grown as tumors in vivo. 
Already at the beginning of the long history of 3D culture, it was understood that this 
system could give important information about the relationship between tumor cells and 
infiltrating host cells, such as fibroblast, macrophages and lymphocyte. In fact, Lees at 
colleagues [29] generated a multicellular tumor spheroids model of HT-29 colon cancer 
cells, grown in vitro and subsequently implanted in the peritoneal cavity of BALB/c mice. 
The spheroids were recovered at various time and, after dissociation, assessed for the 
viability by using a clonogenic assay. Little damage to spheroids was observed during 
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the initial four days after implantation, but more than 99% reduction in clonogenic tumor 
cells occurred between days four and seven. The morphological test (light and electron 
microscopy both in situ on sections and on dissociated suspensions of spheroid cells), 
demonstrated a correlation between spheroids damage and graft in situ destruction with 
host cell infiltration. Fascinating is the system of hybrid spheroid proposed by Lange et 
colleagues [30]. This system was created as prognostic assay with the potential ability 
to predict in vivo radio- and/or chemosensitivity. The hybrid spheroid assay consists on 
a cell suspension directly derived from tumor sample mixed in a known ratio with a 
suspension of clonogenicy inactivated HeLa feeder cells. By adjusting the ratio of tumor 
to feeder cells and by selecting the appropriate size of spheroids, the surviving fractions 
and survival curves of spheroids treated with both ionizing radiations and drugs can be 
calculated with the ratio of clonogenicity observed of treated to untreated populations. 
Using this method Lange et colleagues demonstrated that cells cultivated in hybrid 
spheroids showed a marked resistance to 5-fluorouracil, as they are in vivo. This 
resistance was not seen in monolayer culture system. The model of multicellular tumor 
spheroids was used by Mellor and colleagues [31] to address the clinical relevant 
problem of the heterogeneous population of cells in solid tumors, in which co-exist 
actively dividing cells accounting for only a small proportion of the total, with the 
remainder of the cells being in a quiescent state. Based on this, they developed a 
multicellular tumor spheroids model using DLD-1 human colon adenocarcinoma cells 
supplemented with classical complete medium called TS proliferating (high expression 
of Ki-67 marker) and a quiescent version cultivated in serum-starvation setup, called TS 
quiescent (high expression of quiescence marker p27kip1). Afterwards, the efficacy of 
widely used chemotherapeutic drugs was determined. Vinblastine, doxorubicin, 
cisplatin and 5-fluorouracil all produced significant cell death in the TS proliferating. 
However, while still effective, the potencies of doxorubicin and cisplatin were 
significantly reduced in TS quiescent. Interestingly, 5-fluorouracil and vinblastine did not 
produce cell death in the TS quiescent indicating that within an in vivo tumor subsist 
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micro-regions with cells that have different sensitivity to chemotherapy due to a complex 
ultra-structural organization. Weiswald and colleagues [32] proposed an original study 
in which they spontaneously obtained a 3D culture model, called Colosphere, from CRC 
specimens subjected to mechanical dissociation. Interestingly, they found that original 
tumor specimens classified as AJCC Stage III and IV showed an increased capacity to 
form colospheres (against AJCC Stage I and II) and this was found to be significantly 
correlated with tumor aggressiveness. This aggressive behavior was cancer specific 
because the respective healthy colon tissue failed to do so when processed in the same 
manner. In addition, they also demonstrated that this colospheres not only had a similar 
genetic pattern of the original tissue but also maintains the aggressive phenotype 
causing metastasis when implanted in immunocompromised mice. Recently, with the 
aim of creating an in vitro cellular culture models able to better recapitulate complex 
tissue architecture and mechanical stimuli, the multicellular tumor spheroid culture 
system was coupled with the technology of microfluidic systems integrated in 
bioreactors. In this fascinating scenario, Chen et colleagues [33] developed a micro-
engineered platforms fabricated from PDMS using soft lithography and rapid 
phototyping, highly effective in generating homogenous and massive numbers of tumor 
spheroids with the addition advantages of body fluid flow simulation. Other advantages 
are the capability of generating tumor spheroids with uniform structure, possibility of 
long-term cultivation, and real-time imaging measurement. In this way the complexity of 
the experimental model increases, as there is a diffusion of nutrients and oxygen and 
the development of complex cell-cell junctions. However, although these experimental 
culture models support a 3D ultrastructural organization, it completely lacks the 
structural component represented by the native ECM of the tissue in which cancer cells 
developed and progressed and from which they are mutually influenced and which in 
turn reshape it over time. 
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Tissue engineering applied to oncology: the decellularization process 
In order to recapitulate the 3D organization and ECM of tumors, various natural and 
synthetic materials were developed to provide architectural support to interacting cells 
[34-38]. The first and still most commonly used materials for 3D culture of cancer cells 
were the natural derived-ECM biomaterials such as collagen, laminin, hyaluronic acid 
and Matrigel®. The key properties of these compounds are: inherent cytocompatibility; 
intrinsic cell adhesion properties and ability to be remodeled by cells [39]. However, the 
batch‑to‑batch variability, complex molecular composition and uncontrolled 
degradation of these materials often make difficult to study the influence of particular 
properties of the ECM on tumor cells while maintaining the other variables unaltered. In 
parallel, to overcome the limitations of natural-derived ECM researchers have 
developed synthetic materials such as polyethylene glycol (PEG) and poly(lactide-co‑
glycolide) (PLG) that can provide more precise experimental control over biochemical 
and mechanical properties in modelling the tumor ECM. However, as these synthetic 
materials lack natural cell adhesion sites and are not readily remodeled by cells, cell 
adhesion ligands and biodegradable cross-linkers are often grafted to the polymers. 
In the last ten years, a new model of 3D culture is affirming on the landscape of 
oncological research, which uses biological scaffolds derived directly from the patient 
to design a 3D in vitro culture models that mimics the structural, biochemical and 
biological characteristics of the native tumor. The experimental approach used to 
produce this 3D model is that of tissue decellularization. Decellularized tissues and 
organs have been successfully used in a variety of tissue engineering/regenerative 
medicine applications in order to replace the damaged part of the organ or the complete 
replacement of the impaired organ, and the decellularization methods used vary as 
widely as the tissues and organs of interest [40].  
The term decellularization, means the removal of the cellular component of a tissue by 
minimally altering its biochemical composition and its biological and structural 
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properties. Currently, there is no precise quantitative or qualitative requirements that 
allow to uniquely defining the yield of a tissue decellularization. Based upon the findings 
of studies, the following minimal criteria are sufficient to satisfy the intent of 
decellularization [41]: 
• <50 ng dsDNA per mg of dry weight ECM; 
• <200 bp DNA fragment length of the remaining DNA; 
• lack of visible nuclear material in tissue sections stained with 4',6-diamidino-    
2-phenylindole (DAPI) or Hematoxylin and Eosin satin. 
 
Recently, some promising 3D tumor cell culture models have been developed and 
showed encouraging results in CRC research. This tissue engineering approaches, 
which was defined as “Tumor engineering”, are employed to study tumor cells behavior 
in a 3D culture model that better recapitulate the in vivo situation. For example, 
Genovese et colleagues [42] developed a decellularization protocol of matched 
samples of healthy colon mucosa, peritumoral tissue and CRC. They observed a 
complete removal of cellular compartment and the maintenance of the main structural 
components of colonic mucosa, healthy and CRC, as well as the proper proteins 
distribution along the tissue. In addition, they developed a recellularization protocol for 
repopulating decellularized mucosa with stabilized CRC lines that demonstrated the 
ability to grow and invade the acellular patients-derived scaffolds.  
Another recent work of Pinto et colleagues [43], revealed the relationship between 
macrophages and ECM and the ability of the latter to influence macrophage polarization 
in a physiological environment compared to the CRC. Notably, in this study, healthy 
colonic mucosa and CRC were decellularized and characterized for their biochemical 
and mechanical properties. Afterwards, they repopulated decellularized healthy mucosa 
and CRC with human isolated macrophages in order to evaluate whether normal and 
tumor-decellularized matrices had the ability to differently modulate macrophage 
polarization, in terms of gene expression and secretion of pro- and anti-inflammatory 
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cytokine and chemokine. Interestingly, they showed that normal and tumor 
decellularized ECM distinctly promoted macrophage polarization, with macrophages 
seeded in tumor matrices differentiating towards an anti-inflammatory M2-like 
phenotype. In addition, using an invasion assays they revealed that tumor ECM-
educated macrophages stimulated cancer cell invasion through a mechanism involving 
CCL18. 
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PURPOSE OF THE THESIS 
 
The PhD project that I carried out during these three years had the following aims: 
a) To standardize a decellularization protocol for the healthy colonic ECM and CRC 
counterpart, able to eliminate the cellular component but simultaneously 
maintainings its structure, biochemical composition and biological properties; 
 
b) To characterize the decellularized healthy and CRC ECM by analyzing the main 
structural components, its three-dimensional organization and  the proteome 
and secretome composition; 
 
c) To verify whether the CRC ECM possesses different biological properties 
compared with healthy colonic mucosa by means of recellularization 
experiments with stabilized CRC cell lines. 
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MATHERIAL AND METHODS 
Patients  
A series of 28 paired normal mucosa (N) and cancer lesion (T) tissue samples from 
CRC patients who underwent curative surgery between February 2015 and December 
2016 were collected from First surgery clinic, Surgery Unit at the University of Padua 
(Department of Surgery, Oncology and Gastroenterology) and General Surgery Unit, S. 
Antonio Hospital (Padua). This study was conducted according to the principles 
expressed in the Declaration of Helsinki. Written informed consent was obtained from 
every enrolled individual and ethics committee of institution approved the protocol. All 
of the patients enrolled fulfilled the following inclusion criteria: histologically confirmed 
primary adenocarcinoma of the colon, age > 18 years, and written informed consent. 
Patients with a known history of a hereditary colorectal cancer syndrome and patient 
that underwent neoadjuvant treatments were excluded (Table 2). 
 
 Total (N=28) 
Median age (interval) 72.5 (39-87) 
Sex 
      
 
Male 
Female 
 
17 (60,7%) 
11 (39,3%) 
Grading 
     
 
G1 
G2 
G3 
 
2 (7%) 
19 (68%) 
7 (25%) 
Staging   
I 
II 
III 
IV 
 
4 (14.3%) 
11 (39,3%) 
9 (32,1%) 
4 (14,3%) 
Type of surgical 
   
 
Sigmoidectomy 
Hemolectomy right 
Hemolectomy left 
Abdominoperineal resection of rectum 
 
6 (21%) 
10 (36%) 
7 (25%) 
5 (18%) 
 
Table 2. Clinical and pathological characteristics of N=28 colorectal cancer patients enrolled in the study. 
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Tissue decellularization 
All mucosa specimens encompassed the luminal surface, mucosa and submucosa. 
CRC tissue was obtained at the edge of infiltrating neoplasia and matched healthy colon 
mucosa was obtained more than 10 cm far from the cancer lesion. Surgically obtained 
healthy mucosa and CRC specimens were kept in cold and sterile phosphate buffered 
saline (PBS) for no longer than 2 h before processing. All the decellularization steps 
were performed with sterile solutions and under tissue culture hood. Healthy mucosa 
and CRC destined to be used as fresh samples (FN= fresh normal tissue; FT= fresh 
tumor tissue) were rinsed with sterile PBS and consequently treated according to the 
methodology with which were analyzed. Healthy mucosa and CRC destined to 
decellularization process (DN= decellularized normal tissue; DT= decellularized tumor 
tissue) were treated with one to three detergent-enzymatic treatment (DET) cycles. 
Each DET cycle was composed of deionised water at 4 °C for 24 h, 4 % sodium 
deoxycholate (Sigma) at room temperature (RT) for 4 h, and 2000 kU DNase-I (Sigma) 
in 1 M NaCl (Sigma) at RT for 3 h, after washing in water. After decellularization, 
matrices were rinsed in PBS +3 % penicillin/streptomycin (pen/strep) for at least 5 days 
changing the solution two times a day and then stored at -80 °C. 
 
DNA isolation and quantification  
To assess total DNA content within the fresh healthy mucosa and CRC compared with 
decellularized matrices, 20 mg of each specimen were treated using 
DNeasyBlood&Tissue kit (Qiagen) under manufacturer's instruction. DNA samples 
were then quantified using Nanodrop 2000 spectrophotometer at 260/280 nm ratio 
(Thermo Scientific, USA). Agarose gel (1 %, containing 1 % SYBRsafe) was used to 
separate DNA and bands were visualized by exposing the gel to UV light and images 
acquired by Gel Doc (Biorad). Fresh and decellularized specimens were loaded into the 
gel, and DNA ladder of lambda DNA were used as controls. 
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Immunohistochemistry and immunofluorescence 
Frozen sections (8 µm thick) were stained with Haematoxylin & Eosin (HE; Bio Optica, 
Milan, Italy), Masson trichrome (aniline blue kit; Bio Optica), Alcian blue stain (pH 2.5 
kit; Bio Optica) and Van Gieson trichrome (Bio Optica) for elastic fibers and connective 
tissue, Silver Stain (Bio Optica), Periodic Acid Schiff (PAS; Bio Optica), anti-collagen IV 
[1:100, Dako, Milan, Italy], and anti-Defensin alpha 3 antibody - C-terminal (1:100, 
Abcam, Cambridge, UK). All the stainings were performed according to manufacturer's 
instruction. Immunohistochemical (IHC) stainings were automatically performed using 
the Bond Polymer Refine Detection kit (Leica Biosystems, Newcastle upon Tyne, UK) 
in the BOND-MAX system (Leica Biosystems). 
For immunofluorescence analysis, sections were permealised with 0.5 % Triton X-100, 
blocked with 10 % horse serum and incubated with primary antibodies [Laminin (1:100, 
L-9393 Sigma); Ki-67 (1:100, ab15580 Abcam)], then slides were washed and 
incubated with labelled Alexa Fluor secondary antibodies. Finally, nuclei were 
counterstained with fluorescent mounting medium plus 100 ng/mL 40,6-diamidino-2-
phenylindole (DAPI) (Sigma-Aldrich). For each specimen, random pictures were 
collected with a direct microscope. 
 
ECM component quantification 
Collagen and sulphated glycosaminoglycan (sGAG) content on fresh and decellularized 
healthy mucosa and CRC were quantified using respectively the SIRCOL collagen 
assay and Blyscan GAG Assay Kit (all from Biocolor, UK) under manufacturer's 
instruction.  
 
Scanning electron microscopy (SEM) 
Samples were fixed with 2 % glutaraldehyde in 0.1 M phosphate; following washing they 
were cut into segments of approximately 1 cm length and cryoprotected in 25 % 
sucrose, 10 % glycerol in 0.05 MPBS (pH 7.4) for 2 h, then fast frozen. At the time of 
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analysis, samples were placed back into the cryoprotectant at RT and allowed to thaw. 
After washing, the material was fixed in 1 % OsO4/0.1 M phosphate buffer (pH 7.3) and 
washed again. After rinsing with deionized water, specimens were dehydrated in a 
graded ethanol-water series to 100 % ethanol, critical point dried using CO2 and finally 
mounted on aluminum stubs using sticky carbon taps. Samples were mounted and 
coated with a thin layer of Au/Pd (approximately 2 nm thick) using a Gatan ion beam 
coater. Images were recorded with a Jeol 7401 FEG scanning electron microscope. 
 
Mass Spectrometry analysis 
Paired normal mucosa/tumor tissues (average weight 33.8 mg) were decellularized and 
analyzed by mass spectrometry as follow. 
 
Samples preparation 
Normal/tumor tissue secretome was collected by implementing the original procedure 
proposed by de Wit et al. (23) with a sequential extraction procedure. Briefly, 
decellularized samples were cut to 1 mm3 pieces and placed in 50 mM ammonium 
bicarbonate buffer at 4 °C for 1 h to collect low-bind proteins of secretome. Surnatant 
(fraction A) was removed and concentrated onto 30 kDa MWCO centrifugal filters 
(Amicon Ultra, Millipore). A second extraction of decellularized ECM was performed in 
presence of 7 M urea, 20 mM dithiothreitol (DTT), 0.5 % SDS in 50 mM ammonium 
bicarbonate (1h at 56 °C) to recover cross-linked secreted proteins within the matrix. All 
reagent were of highest purity available from Sigma-Aldrich. Surnatant (fraction B) was 
removed and concentrated onto 30 kDa MWCO centrifugal filters. Fractions A and B 
were reduced (20 mM DTT, 1h at 56 °C) and alkylated (50 mM iodoacetamide (IAA) 30 
mins, in the dark) and then digested with trypsin (final protein to trypsin ratio 1:50). The 
remaining decellularized ECM was then treated with 50 mM of IAA in ammonium 
carbonate (30 mins, in the dark) and finally dehydrated with 0.25 mL of acetonitrile 
before performing the in-matrix digestion of residual insoluble proteins. Dehydrated 
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ECM samples were digested overnight at 37 °C in presence of a 100 µg/mL trypsin 
solution (Sequencing Grade Modified Trypsin PROMEGA) added to the completely re-
hydrate the ECM pieces. After digestion, samples were centrifuged (14000 rpm, 30 min 
at 4 °C) to collect surnatant (fraction C). The extraction performances in terms of 
reproducibility, specificity and efficacy have been evaluated in the sequential extraction 
of two independent samples of healthy human colonic mucosa (data not shown). 
 
MALDI-TOF and MALDI-TOF/TOF analysis 
Mass spectra of digested peptides were acquired using an Ultraflex II TOF/ TOF (Bruker 
Daltonics, Bremen, Germany) instrument equipped with an Nd:YAG laser ( 355 nm) 
and operating in reflectron positive ion mode in the mass range 500-4000 m/z. External 
mass calibration was based on the monoisotopic values of peptides present in the 
Peptide Calibration Standard II (Bruker Daltonics, Bremen, Germany). Before 
deposition onto the MALDI plate, samples were desalted with ZipTipC18 (Millipore, 
Darmstadt, Germany) following the manufacturer instruction; purified peptides were 
eluted in 1 μl of α-CHCA saturated solution in 50 % acetonitrile and 0.1 % trifluoroacetic 
acid. mMass open source software was employed for spectra alignment, denoising 
(precision 15, relative offset 25, arbitrary units) and smoothing (Savitzky–Golay filtering, 
m/z 0.15) before manual peak picking (threshold set S/N> 6) and intensity normalization 
following the TIC (Total Ion Count) procedure.  
Tandem mass spectra were subjected to Mascot search engine (Matrix Science, 
London, UK) for proteins identification. Search parameters were set as follow: database, 
Swiss-prot; enzyme, typsin; taxonomy, Homo sapiens; precursor ions tolerance, 0.2 Da, 
MS/MS fragments tolerance, 0.8 Da; fixed modification: carbamidomethyl (C); variable 
modifications: oxidation (H,M,P,K), deamidation (N,Q), amidation (C terminal), 
phosphorylation (ST), and acetylation (K, N terminal).  
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Chicken chorioallantoic membrane assay  
Chicken chorioallantoic membrane (CAM) assay was used as previously described [44]. 
Fertilized chicken eggs (Henry Stewart and Co.) were incubated at 37 °C and constant 
humidity. At 3 days of incubation, an oval window of approximately 3 cm in diameter 
was cut into the shell with small dissecting scissors to reveal the embryo and CAM 
vessels. The window was sealed with tape and the eggs were returned to the incubator 
for a further 5 days. At day 8 of incubation, 1 mm diameter acellular matrices were 
placed on the CAM between branches of the blood vessels. Polyester sections soaked 
overnight either in a PBS solution or in PBS with 200 ng/mL VEGF were used as 
negative and positive controls, respectively. Samples were examined daily until 10 days 
after placement wherein they were photographed in ovo with a stereomicroscope 
equipped with a Camera System (Leica) to quantify the blood vessels surrounding the 
matrices. The number of blood vessels (less than 10 μm in diameter) converging 
towards the placed tissues was counted blindly by n=4 assessors, with the mean of the 
counts being considered. 
 
ELISA test 
The concentration of alpha Defensin 3 in fresh and decellularized (healthy colon 
mucosa and CRC) tissue samples was measured using commercially available ELISA 
kit, according to the manufacturer’ instructions (Human DEFA3/Defensin Alpha 3 ELISA 
Kit (Sandwich ELISA) - LS-F6599, LifeSpan Biosciences, Inc). 
 
RNA extraction and qRT-PCR 
In the in vitro experiments, total RNA was extracted using RNeasy Mini Kit (Qiagen), 
according to the manufacturer’s instructions. In the recelullarized sample, total RNA 
was extracted using TissueLyser (Qiagen) combined with Trizol, according to the 
manufacturer’s instructions. The concentration and purity of the RNA were determined 
by NanoDrop 2000 spectrophotometer (Thermo Scientific, USA). The quality of RNA 
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was considered to meet the requirements if the Optical Density (OD) ratio at 260 nm/280 
nm was between 1.7 and 2.1.  
cDNA was synthesized from 500 ng of total RNA using the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA), according to the 
manufacturer’s protocol by the VeritiTM 96-well Thermal Cycler instrument. qPCR was 
performed using the 7500 Fast Real-Time PCR System (Applied Biosystems) with 
HPRT1 gene as endogenous control (Assay ID: Hs99999909_m1). The amplification 
reaction was conducted in a final volume of 20 µl using 4 µl of cDNA, TaqMan® 
Universal PCR Master Mix 1X (Applied Biosystems) and specific TaqMan® Gene 
Expression Assay 1X (Applied Biosystems): Hs00174103_m1 (amplicon length 101 
bp) for CXCL-8 or IL-8. The thermal conditions included one cycle at 50 °C for 2 mins 
for the UNG incubation and at 95 °C for 10 mins for the polymerase activation, followed 
by 40 cycles at 95 °C for 15 s for denaturation and at 60 °C for 1 min for annealing and 
extension. Each sample was run in duplicate and the threshold cycle (Ct) average was 
used for the calculations. The results from each sample were compared with one cDNA 
sample as calibrator, using the 2-Ct calculation method. The fold change was 
expressed as Relative Quantification (RQ). 
 
In vitro experiments 
Conditioned Medium Assay 
The human colon adenocarcinoma cell line HT-29 was obtained from American Type 
Culture Collection (ATCC) and maintained in RPMI-1640 medium supplemented with 
10 % fetal bovine serum, 1 % L-Glutamine and 1 % Penicillin/Streptomycin antibiotic 
solution (Growth medium, [GM]) in humidified atmosphere at 37 °C in 5 % CO2. For the 
preparation of Conditioned Medium (CM), 150 mg of fresh/DET normal/CRC samples 
were disaggregated in 1 mL of GM using TissueLyser (Qiagen) equipped with 7 mm 
stainless steel beads (two cycles, 2 min each at 30 Hz). HT-29 cells were seeded at a 
density of 4x104 cells/well in a 24-well plate tissue culture and incubated at 37 °C in 5 
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% CO2 for 24 h. After 24 h, GM was collected and replaced with CM (control wells were 
replaced with GM). After 48 h of incubation, cells were detached using 0.025 % trypsin 
for 5 min at 37 °C and RNA was collected as specified above for downstream analysis. 
 
In vitro Migration Assay 
HT-29 cells (4x104 cells/well) were plated on uncoated upper chambers (24-well inserts; 
pore size, 8 µm; Sarstedt) for trans-well migration assay. The medium in the top 
component was replaced with conventional GM 12 h after seeding. At the lower 
compartment, DN and DT matrices were added. Cells were allowed to migrate for 24 h, 
and then the cells on both sides of the chamber were fixed with 4 % PFA for 5 min at 
RT and permeabilized with 100 % methanol for 20 min. Cells at the bottom of the 
chamber were stained with Mayer Acid Emallume. Then, picture of each well was taken 
and cell nuclei in each field was counted using Image-J software.  
 
Acellular matrices recellularization 
Match DN and DT matrices were washed with PBS and incubated overnight with RPMI-
1640 medium supplemented with 10 % fetal bovine serum, 1 % L-glutamine and 1 % 
Penicillin/streptomycin antibiotic solution at 4 °C. Before repopulation, in order to 
normalize intra-sample variability, DN and DT matrices were cut with a 5 mm diameter 
stainless steel puncher (Kai Medical). Normal and tumor-derived matrices were then 
transferred into a 6-well plate and fixed to an agarose support with pins. Subsequently, 
1x106 HT-29 cells were resuspended in 15 μL of Matrigel (diluted 1:10 with RPMI-1640), 
carefully placed over the sample and incubated for 3.5 h in humidified atmosphere at 
37 °C in 5 % CO2. Finally, conventional growth medium was carefully added and 
changed every 2 days. HT-29 cells were cultured in 3D acellular matrices for 5 days. 
For each matched samples, recellularization experiments were performed in double. 
For the creation of a 3D synthetic environment, HT-29 cells were cultured in HyStem® 
Hydrogels kit; it’s includes Thiol-modified sodium hyaluronate (HyStem®), Thiol-
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reactive PEGDA crosslinker (Extralink®), Thiol-modified collagen (Gelin-S®) and 
deionized water (DG Water). HT-29 cells (1x106 cells) have been encapsulated in a 
solution mix (Gelin-S and HyStem) in a 1:1 volume ratio into a 24 well plate and after 
30 min added Extralink. Gel was incubated for 3 h in humidified atmosphere at 37 °C in 
5 % CO2. Finally, conventional growth medium was carefully added. HT-29 cells were 
cultured in HyStem® Hydrogels for 5 days with or without exogenous DEFA3 (5ng/mL). 
 
Sample analyses and distribution 
Collected samples were divided into the experimental tests as follows: setting-up of 
decellularization protocol and DNA content evaluation: n=3 matched samples. 
Immunohistochemestry and Immunofluorescence: n=4 matched samples. Collagen and 
GAGs quantification: n=6 matched samples. Scanning electron microscopy analysis: 
n=3 matched samples. Mass Spectrometry analysis: n=3 matched samples were used 
to set-up the experimental conditions of sample preparation and analysis, experimental 
data were generated by analyzing n=5 matched sample. CAM assay: n=6 matched 
samples. ELISA test for DEFA3 quantification: n=11 matched sample. Conditioned 
medium assay: n=6 matched samples. In vitro Migration Assay: n=5 matched samples. 
Acellular matrices recellularization: n=4 matched samples. A total of n=56 matched 
sample were collected and employed from 28 patients enrolled in the study. 
 
Statistical analyses 
All graphs and statistical analysis were performed using GraphPad Prism Software v.5. 
Data are expressed as means ± SEM. For comparison between experimental and 
control group two-sided Student’s t-tests (for parametric dataset) and Mann-Whitney 
test (for non-parametric dataset) were used. One-way ANOVA with Bonferroni's post-
test (for parametric dataset) and Kruskal-Wallis test with Dunns post-test (for non-
parametric dataset), was performed for multiple comparisons. A p-value <0.05 was 
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considered statistically significant (*: p-value <0.05; **: p-value <0.01; ***: p-value 
<0.001). 
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RESULTS 
 
Decellularization efficiency 
Matched samples from both normal (non-neoplastic, N) and tumor (T) specimens were 
decellularized using detergent-enzymatic treatment (DET). After each cycle, DNA 
amount was quantified in order to find the best cycle number in terms of nuclei depletion 
and genetic material removal. Both N and T samples were completely decellularized 
after 2 DET cycles with a reduction of 96.26 % and 94.35 %, respectively (p-value= 
0.0033 and p-value= 0.015, Figure 2A,B and Supplementary figure 1). At first, a general 
overview of tissue architecture maintenance was performed through HE, van Gieson 
and Silver stains, in order to characterize the decellularized samples (DN = 
decellularized normal tissue, DT = decellularized tumor tissue; Figure 2C). As 
underlined by histology, decellularized samples preserved the structure and the main 
protein composition that resulted similar to the fresh tissues (FN = fresh normal tissue; 
FT = fresh tumor tissue; Figure 2C). Moreover, SEM analysis confirmed the 
ultrastructure maintenance also after decellularization process (Figure 2D). 
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Figure 2: Decellularization efficiency. (A) Gross appearance of normal healthy mucosa (N) and tumor 
(T) biopsies before and after 2 cycles of decellularization. (B) DNA amount quantification of N and T 
samples after different detergent enzymatic treatment (DET). (C) Fresh (FN and FT) and decellularized 
(DN and DT) samples histologies. (D) Scanning electron microscopy of fresh and decellularized biopsies. 
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Decellularized tissue characterization 
As second step, we characterized through histology and protein quantification the DN 
and DT matrices composition. Despite MT and collagen IV stains showed the presence 
of collagens in fresh and decellularized tissues with maintenance of distribution pattern, 
protein quantification highlighted a decrease of total collagens in decellularized samples 
with respect to the fresh counterparts (87.28 % of protein loss in DN, p-value=0.025 and 
79.5 % in DT, p-value= 0.0141; Figure 3A,C). About the latter, our histological results 
are consistent with literature findings in which an increase of collagen cross-linking in 
tumor is reported [45-47]. Therefore, the enzymatic treatment we used through pepsin 
digestion for the precipitation and quantification of collagens was more efficient in FN 
respect to FT samples probably due to the less proportion of cross-linking. Moreover, it 
is evident that non cross-linked collagens are more sensitive to our decellularization 
protocol in respect to those are cross-linked, leading to a slightly greater loss of 
collagens in the healthy tissue than in tumor. This discrepancy between histology and 
protein quantification was partially confirmed also after GAG analysis. Indeed, AB and 
PAS stains evidenced the presence of GAG in both fresh and decellularized tissues, 
but quantification of sulphated GAG was quite different between N and T samples: a 
significant decrease in protein quantity was found in DN in respect to FN (p-value=0.03; 
71.35 % of protein loss), whereas no meaningful differences were found between DT 
and FT (p-value=0.19; 60 %; Figure 3B,D). Importantly, immunostaining for laminin, 
another major ECM component, clearly demonstrated that after DET this glycoprotein 
is uniformly distributed through the decellularized samples and the immunostaining 
confirmed the preservation of ordered and physiological villi in DN and at the same time 
a disorganized and unstructured tissue in DT (Figure 3E). 
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Figure 3: Decellularized tissue characterization. (A) Masson’s Trichrome (MT) and collagen IV (Col IV) 
stains for the detection of collagens in fresh and decellularized samples. (B) Alcian blue (AB) and periodic 
acid–Schiff (PAS) stains for the detection of polysaccharides, glycoproteins and glycolipids in fresh and 
decellularized samples. (C-D) Quantification of collagens (I to V) and sulphated glycosaminoglycans 
(sGAG) in fresh and decellularized samples. (E) Immunofluoresence of Laminin in fresh and decellularized 
samples. Nuclei are counterstained with DAPI. 
 
 
Proteomic analyses of decellularized tissue secretome and migration assay 
To better analyze tissue protein maintenance also after decellularization process, a 
mass spectrometry analysis was performed. By MALDI-TOF/TOF analysis, a total of 71 
non redundant proteins were identified in the three collected fractions (fraction A, B, and 
C) of decellularized samples (Table 3). The sequential extraction procedure has been 
developed to collect low-bind secreted proteins (fraction A), cross-linked within the 
matrix secreted proteins (fraction B) and residual insoluble secreted proteins (fraction 
C). This procedure ensured a good reproducibility (CV % in two independent sample 
extraction procedures < 3 %) and a strong selectivity in the collect unique ionic species 
(m/z) in the three fractions (data not shown). Identified proteins were then classified on 
the basis of their predicted localization following the ProteinAtlas database classification 
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(http://www.proteinatlas.org/). Venn diagram reported in Figure 4A shows the predicted 
distribution of identified proteins in decellularized tissues.  
 
Figure 4: Proteomic analyses of decellularized tissue secretome and migration assay. (A) Venn di-
agram showing the predicted localization of proteins detected in decellularized samples. (B-C) Comparison 
of detected protein abundance in decellularized healthy tissue (DN) vs tumor tissue (DT).  (D) Invasion 
assay: representative images of HT-29 cell migration after incubation medium only (Ctrl), DN and DT sam-
ples. Graph shows the number of cells per field that migrated through the trans -well in each type of sample 
(counts were made in blind by 2 operators). 
 
As expected, most of detected proteins were predicted to be secreted, whereas several 
others were predicted to be intracellular with the actin-related proteins and myosins as 
the most representative groups. We hypothesized that observed signals were related 
only to residual proteins fragments trapped into the matrix by covalent (i.e. sulphur 
bridges) or non-covalent (i.e. Van der Waals or hydrophobic) interactions. 
We then compared the relative abundance of detected proteins to identify key 
components in DT with respect to the DN counterpart. A peak list (m/z, intensity) was 
obtained from the full scan mass spectra of collected fractions from ECM. Obtained 
peaks were filtered based on frequency criteria and only peaks observed in 60 % of 
samples (i.e. at least in 3 out of 5 analyzed samples) were retained. A threshold in the 
tumor to normal mucosa ratio of 1.5 fold change has been considered to select those 
proteins characteristics of tumor tissue (Table 3) and all the proteins presenting a < 0.6 
fold change were considered characteristics of normal tissue. 
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Table 3: List of identified proteins and their relative abundance in normal and tumor tissues. 
 
 
All the detected proteins were divided on the basis of their activity or field of action. 
Among those involved in biological processes, we identified 22 total proteins 6 of which 
were equally present in the analyzed samples, 7 more present in the DN and 9 more 
present in the DT (Figure 4B). About ECM and ECM-related protein, we found 30 total 
proteins, of which 14 equally present between DN and DT, 9 more present in healthy 
tissue and 7 more present in tumor samples (Figure 4C). Since among all the detected 
proteins, there were also those responsible or involved in cell attraction and migration 
such as STOML2 and TNS4 [48, 49] and relying on previous works, in which acellular 
scaffold showed to be able to induce cell invasion [50, 51], we decided to evaluate the 
impact of DN and DT samples on cell migration. Accordingly, HT-29 cells were attracted 
with DN and DT matrices using an in vitro transwell-based invasion assay. We observed 
Common proteins Normal tissue proteins    
(< 0.6 fold change) 
Tumor tissue proteins        
(> 1.5 fold change) 
ADAM10 PCDH11Y AMER3 
ADAM22 C6 COL1A1 
AMOTL2 CD55 COL1A2 
BACE1 COL6A2 COL3A1 
CASP10 COLGALT2 DEFA3 
COL5A1 DES EMCN 
COL6A1 EFEMP1 EPX 
COL6A3 FBN1 FGA 
COL6A6 HSPB1 FGB 
COL8A2 HSPG2 HIF1A 
DMKN PCDH18 MMP24 
FLNA PCDHGC5 PCDHGC4 
HIF1AN PITPNM1 PLEKHG5 
HIST1H2B SIGLEC1 PRG2 
HIST1H2B TAGLN PRRT2 
HSPB6 TNC STOML2 
KRT1 TPM2 TNS4 
LAMA3 TRAM1  
LAMB4 VIM  
LGALS1   
LGALS7   
MXRA5   
MYL11   
PLEKHA5   
PRRT4   
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that decellularized matrices were able to attract a greater cell amount in respect to the 
control (only medium; Figure 4D), and that invasion ability of HT-29 cells with DT 
samples was significantly increased in respect to cells conditioned with DN (p-value= 
0.0006; Figure 4D), confirming what found previously with proteomic analysis in which 
STOML and TNS4 were found more abundant in tumor samples. This result 
demonstrated the ability of the acellular matrices to release soluble factors retained 
after decellularization and support the data obtained by proteomic analysis. 
 
Decellularized tissue biologic activity 
To test the bioactivity of DN and DT samples in relation to the peptides retained in the 
ECM also after the decellularization process, we analyzed the effect of a representative 
factor, DEFA3 that was found significantly more abundant in tumor samples after 
proteomic analysis. To confirm the presence of DEFA3, we performed ELISA test and 
immunostaining to detect and localize the protein inside the matrices (Figure 5A,B). It 
is known in literature that DEFA3, a human neutrophil peptide with antibiotic activity and 
abundantly secreted upon neutrophil activation, possess anti-angiogenic properties 
[52]. We verify the angiogenic activity of our decellularized matrices using CAM assay, 
a standard in vivo test: 10 days after in ovo samples application, DT specimens were 
able to attract significant less vessels and capillaries in respect to DN samples (p-value= 
0.0066; Figure 5C). Moreover, it is reported that the stimulation of tumor cell lines with 
DEFA3 resulted in the induction of IL-8 overexpression [53, 54]. Also in our hands, 
stimulation of HT-29 cell line with exogenous administration of DEFA3 (Figure 5D) or 
CM obtained through DN and DT matrices disaggregation (Figure 5E) induced the 
overexpression of IL-8 in respect to the untreated cells (Figure 5D,E), even though this 
expression was not significantly different between DN and DT conditioned cells. 
Importantly, HT-29 cells seeded over DN and DT patient-derived matrices and let to 
colonize and partially repopulate the 3D environment for 5 days, as indicated by HE and 
staining for the proliferation marker KI67 (Figure 5F), showed a significant 
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overexpression of IL-8 transcript in DT compared with DN samples (p-value=0.004; 
Figure 5G). This property seems to be related to the synergic effect of 3D acellular 
matrix conformation and DEFA3 spatial availability given that HT-29 cells cultivated in 
3D inert gel did not overexpressed IL-8, neither when proportional concentration of 
DEFA3 was added to the culture medium (Figure 5G). Taken together this data indicate 
that our decellularized patient-derived matrix not only maintains unaltered its physical 
and structural properties but also has pro-active biological features, based on the 
original characteristics. 
 
Figure 5: Decellularized tissue biologic activity. (A) ELISA test for the detection of DEFA3 in fresh and 
decellularized samples from both healthy mucosa and tumors. (B) Anti-DEFA3 immunostaining in DN and 
DT biopsies (insert: fresh tissues). (C) CAM assay: gross appearance after 10 days of of in ovo samples 
application and HE staining of the collected samples. Graph shows the quantification of attracted chicken 
vessels and capillaries. Counts were performed in blind by 4 operators. (D) Expression of IL-8 transcript 
after increasing administration of DEFA3 in HT-29 cells. (E) Expression of IL-8 transcript by HT-29 cells 
culture in basal medium (Ctrl), or conditioned medium obtained after mechanical disaggregation of 
decellularized healthy tissue (DN) and tumor tissue (DT). (F) Histological appearance of representative 5 
days 3D culture of HT-29 cells with DN and DT samples. Haematoxylin and Eosin (HE), Immunofluoresence 
with Laminin (green), KI67 (red) and nuclei (blue). (G) Expression of IL-8 transcript by HT-29 cells after 5 
days of 3D culture over inert gel (HyStem® Hydrogels) with or without exogenous DEFA3 (5ng/mL), DN 
(DN 3D) or DT (DT 3D) samples. Cells cultured on 2D plastic dishes were used as controls (Ctrl 2D).  
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DISCUSSION  
In this thesis, we demonstrated that decellularization is a valid approach to obtain an in 
vitro 3D microenvironment from healthy colon mucosa and CRC specimens that 
maintains peculiar biological activity depending on the original physiological or 
pathological condition.   
Genetic alterations impairing the tightly controlled systems of cellular homeostasis are 
responsible for the onset of CRC. Despite the important knowledge derived from genetic 
analyses and the discovery of relationship among mutations and tumor progression, 
less is known about the role of cell and tissue microenvironment interaction in cancer 
development. In the last decade, the cancer cell-centric view has been flanked by the 
tumor microenvironment concept. In this context, the most abundant component of 
tumor microenvironment is the ECM that provides critical biochemical and biophysical 
properties influencing cell differentiation, polarity, growth, survival, proliferation and fate. 
Although this idea is being established, at present there are no 3D culture models able 
to provide the correct in vitro mechanical and biochemical stimuli to be used as reliable 
assays in pre-clinical studies.  
In this scenario, we propose a tissue decellularization method that allows achieving 
excellent nuclei depletion preserving ECM components starting from patient biopsies. 
We developed a decellularization protocol that combines the use of a Sterile milli Q 
water coupled with ionic detergent and DNase I. To date, most of the decellularization 
protocols currently used in oncological research relies on a linear development with long 
incubation times [50, 55, 56]. On the contrary, our approach involves a cyclic 
decellularization with short incubations in each solution. In this way, it is possible to 
identify with greater precision the number of cycles required for nuclear depletion, 
avoiding excessive loss of ECM components. In this study, paired normal mucosa and 
CRC tissues were decellularized employing sodium deoxycholate (SDC) as detergent. 
SDC is a ionic detergent frequently used throughout distinct decellularization protocols, 
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often in combination with several zwitterionic detergent due to its mild properties [41]. 
In literature, the majority of DET protocols uses sodium dodecylsulfate (SDS), a strong 
ionic agent, even though it has been proven that tends to disrupt native tissue structure, 
to remove GAG and to damage collagens [41]. Here, we proposed a DET protocol in 
which SDC and DNase I are able to remove more than 95 % of DNA content unchanging 
tissue composition and organization. Histological, immunohistochemical and 
ultrastructural evaluations confirmed the preservation of native tissue architecture and 
major ECM components (as laminin, collagen type IV and GAG). GAG preservation is 
crucial to maintain the biological activity of our patient-derived scaffolds. In fact, it has 
been demonstrated that GAG bind many growth factors and allow the specific and 
organized localization of ligands and associated proteins, such as mucins, complement, 
metalloproteases and their inhibitors, latent TGF-β, divers growth factors and 
chemokines [43]. As reported by others, GAG loss is an inevitable side effect of DET, 
because glycans are one of the most easily leachable component of the ECM and are 
also present in large amount on cell membranes that are totally removed along the DET 
process. Notably, in our study the loss of GAG is smaller compared with other similar 
studies [43]; moreover, the method we used for their quantification is not sensible to 
Hyaluronan, a glycan that is known to be excessive accumulated in breast [57], gastric 
[58] and colorectal [59] cancer tissues, probably underestimating the total 
concentration, especially in tumor samples, that in our hands seems more reliable with 
the histological readout. Through immunohistochemistry, qualitative evaluation of 
collagen distribution in (decellularized) normal vs tumor tissues showed, in agreement 
with the literature, a general increase in collagen deposition that consequently causes 
a tissue stiffness increment known as desmoplastic reaction [60]. At a first sight, in the  
decellularized samples, the quantification of collagens I to V seems to highlight their 
reduction in tumors compared with healthy mucosa. Based on these data we hypothized 
that the method used to solubilize collagen (pepsin incubation) fails to extract the total 
collagen amount, because in the pathological tissue it is strongly cross-linked with other 
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ECM components, especially with elastin [61]. Tumor ECM stiffening is caused, in part, 
by a raised activity of lysyl oxidase (LOX), the enzyme responsible for the cross-linking 
between collagen and elastin molecules [61]. Similarly to what found in other tumors, 
LOX was described to be upregulated in CRC comparing to normal colon and was 
shown to promote CRC progression [45]. This phenomenon was confirmed analyzing 
proteomic data of the collagen family peptides. We found that our decellularized CRC 
tissue possesses an increased content in COL1A1, COL1A2 and COL3A1 compared 
with healthy mucosa, as described by literature [62]. The occurrence of an active 
remodeling process in the analyzed DT samples was confirmed by the presence of 
MMP24. These data are in line with previous observations highlighting the CRC ability 
to deposit more dense and ordered collagen fibers in replacement of the proteolitically 
degraded normal stroma [63]. Decellularized normal colonic mucosa was characterized 
by the presence of several intracellular proteins, including vimentin, desmin, transgrelin 
and tropomyosin 2. A peculiar class of intracellular/membrane proteins found abundant 
in normal tissue is the protocadherins family (PCDH11Y, PCDHGC5, PCDH18). With 
respect to normal tissue, the cell-matrix adhesion proteins in cancer tissues were 
strongly down regulated, with the exception of protocadherin gamma C4 (PCDHGC4). 
Up to now, evidences of protocadherins involvement in cancer progression are very 
limited, but in general they act as tumor suppressor [64]; their down regulation in tumors 
increases cell proliferation and migration and some of them have been implied in the 
colorectal carcinogenesis [65]. In fact, adhesion molecules play a vital role in the 
induction and maintenance of tissue differentiation and their down-regulation has been 
previously implicated in CRC progression [66]. In the DT samples, the concomitant 
presence of high levels of endomucin (also known as Mucin-14), which is known to 
interfere with the assembly of focal adhesion complexes and to inhibit the interaction 
between cells and ECM, strongly evidence the tumor ability to regulate cell growth and 
differentiation.  
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A fundamental feature that a biologic-derived scaffold should possess is the ability to 
exert a biological activity even after deprivation of resident cells. From this point of view, 
we analyzed our decellularized samples demonstrating that, in addition to the 
architecture and the protein composition maintenance, also small molecules and 
soluble factors have been preserved with our decellularization protocol, conferring to 
the acellular ECM many of the biological properties already present in the native tissue. 
First, decellularized tumor samples have been shown to be more chemo-attractive than 
healthy samples against HT-29 cell line. This property is supported by the panel of 
peptides found more abundant in the tumor samples after proteomic analysis, some of 
which are related to immune system activation and regulation (EPX, PRG2, and 
DEFA3) and others directed involved in cell migration and motility, such as STOML2, 
HIF1α and TNS4 [48, 49, 67]. Secretoma analysis showed a marked increase of DEFA3 
in tumor stroma compared to healthy counterpart. DEFA3 belong to the family of alpha-
Defensin peptides and is part of the innate immune response active against a variety of 
bacteria, fungi, parasites and some viruses. DEFA3 is synthesized in neutrophil 
precursor cells, and mature circulating neutrophils release DEFA3 in inflammation 
areas. The gastrointestinal tract is a prominent site of DEFA3 secretion but recently a 
study described an elevated amount of DEFA1-3 in plasma and tumor tissue from 
patients with CRC and its correlation with prognosis and response to therapy in 
advanced CRC [68]. A study of Chavakis and colleagues demonstrated that the direct 
effect of DEFA is to induce apoptosis in endothelial cells, to inhibit endothelial cell 
adhesion and migration, exerting in general an anti-angiogenic effect [52]. After 
proteomic analysis, we confirmed the presence of this anti-angiogenic factor inside the 
decellularized tumor samples not only by ELISA and immunostaining, but especially by 
CAM assay that clearly demonstrated the less vessel attraction exerted by tumor matrix 
in respect to healthy tissue. This is an important finding since DEFA3, as indirect 
effector, is strongly related with inflammation and cancer. Indeed, neutrophils are 
prominent disease promoter, contributing to important steps during tumor progression 
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and metastasis [69]. Moreover, direct cancer-promoting effects were further 
demonstrated in a study where neutrophil extracellular traps (NETs), web-like structure 
in which chromatin and several proteins are externalized, were suggested to contribute 
to tumor relapse after surgery in patients with metastatic CRC [70]. Given that DEFA3 
is one of the different class of proteins released in the microenvironment after neutrophil 
dead (known as NETosis or vital NETosis [71]), it is possible that contributes to the 
mechanism by which neutrophils increase tumor growth and progression. In literature, 
it has been shown that the release of neutrophils proteins into the inflamed tumor stroma 
is a strong activator of angiogenesis through stimulation of chemokine CXCL-8, also 
known as IL-8 [54]. In addition, a recent research work showed that released DEFA 
proteins are able to induce the secretion of IL-8 in HT-29 cell line through the activation 
of ERK1/2 signaling pathway [53]. Also in our hand, HT-29 cells were able to over-
expressed IL-8 transcript after conditioning with either exogenous or decellularized 
matrix-related DEFA3, but this increase in gene expression was statistically different 
between acellular tumor and healthy mucosa samples only when the cell line was 
cultivated in 3D biologic-derived environment. This finding highlights the importance of 
architecture and spatial (and maybe temporal) availability of peptides and factors 
retained by the scaffold, and strongly supports the idea that acellular matrix obtained 
via decellularization resembles the original microenvironment. Therefore, this approach 
could be very useful in improving in vitro pre-clinical studies given that mimics more 
effectively the in vivo environment than conventional 2D cultures. Indeed, decellularized 
ECM allows cell growth and adaptation to a rich protein milieu respecting their timing, 
mechanical, and biological signal requirement. Moreover, it would also allow reducing 
in vivo xenogeneic tests, becoming not strictly necessary having the ability to recreate 
in vitro a reliable tissue-like structure. More experiments needed to confirm our results 
and to deeper investigate ECM biological properties relating the presence of diverse 
peptides to different tumor conditions such as CRC stages or aggressiveness and 
therapy resistance. 
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CONCLUSIONS 
With this thesis, we demonstrated that detergent enzymatic treatment is a good 
decellularization method to obtain acellular scaffold from both healthy and tumor 
biopsies. Our protocol allows preserving original structure, ultrastructure, architecture, 
and protein composition. Moreover, peptides and small molecules retained in the 
decellularized matrices maintained biological activity and effect, nominating this 
technique an interesting approach to overcome obsolete 2D culture models and to 
perform more relevant in vitro 3D clinical screening and drug delivery assays. 
 
 
FUTURE PERSPECTIVE 
The present work allowed us to produce a scientific paper currently submitted to the 
peer-review journal “European Journal of Cancer”. Based on these encouraging results 
we have decided to apply this approach to the study of the metastatic CRC (mCRC) 
environment. Liver is the most common site for CRC metastasis: about 50% of CRC 
patients develop liver metastases during the disease progression and in 15-25% of 
patients it is already present at diagnosis. In addition, the highest mortality rate in this 
disease is in the case of mCRC. The experimental results of this thesis have shown 
how the decellularization protocol is an effective method for producing acellular 
scaffolds that allow us to study the influence of the non-cellular component of the tumor 
niche.  
In the light of these promising results, the laboratory in which I carried out this project 
established a scientific collaboration with the Foundation For Liver Research - Institute 
of Hepatology (Denmark hill campus of King’s College of London). The future objective 
is to study the tumor microenvironment of liver metastasis niche derived from primitive 
CRC. In this project, in addition to standardizing a new decellularization protocol, we 
are going to study the proteome and secretome profile of the mCRC in comparison with 
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healthy liver and with primitive CRC. In addition, CRC liver metastasis will be 
repopulated with primary CRC cells to perform pharmacological treatment tests and 
consequently evaluate the response to treatment in the acellular patients-derived 3D 
environment in comparison with conventional 2D plate. 
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